Green Fresh Biotechnology Company Limited (stock short name: GREEN FRESH BIO) released its monthly return for the period ended 31 May 2026, confirming stable share capital and continued compliance with Hong Kong listing rules.

Authorised Share Capital • The company’s authorised ordinary share capital remained unchanged at 50.00 billion shares with a par value of HKD 0.01, equivalent to HKD 500.00 million.

Issued Share Capital and Treasury Shares • Issued ordinary shares (excluding treasury shares) stood at 874.12 million, identical to the prior month’s balance. • The company held no treasury shares, and there were no new issuances, cancellations, conversions or repurchases during the month.

Public Float Compliance • GREEN FRESH BIO affirmed that, as at 31 May 2026, it satisfied the Main Board’s minimum public float threshold of 25% of issued shares.

Capital-Raising Instruments • The filing recorded no outstanding or newly issued share options, warrants, convertible securities or other equity-linked instruments.

Governance Confirmation • The company secretary confirmed that all regulatory and listing rule requirements were met for the period, with no undisclosed issues regarding securities issuance or treasury share activity.

The absence of share capital changes in May signals a period of stability for GREEN FRESH BIO’s equity structure, while the confirmed public float compliance underpins ongoing adherence to Hong Kong Exchange listing standards.